Home

Nordest cousin Mal comprendre achim aigner leipzig university germany hybride Conquérir analyser

Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma  exerts multiple cellular and molecular antitumor effects | Scientific  Reports
Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects | Scientific Reports

Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs
Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs

Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma

Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon  Carcinoma
Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma

Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis  in prostate carcinoma and melanoma
Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology

MedTech-2022 Conferences | MedTech -2022 | MedTech 2022 Events | Pharma  Industry and MedTech | MedTech Conferences | MedTech Meetings | Pharma  Industry and MedTech | | Pharma Industry and MedTech Congress
MedTech-2022 Conferences | MedTech -2022 | MedTech 2022 Events | Pharma Industry and MedTech | MedTech Conferences | MedTech Meetings | Pharma Industry and MedTech | | Pharma Industry and MedTech Congress

Multiple effects of the special ATâ•'rich binding protein 1 (SATB1) in  colon carcinoma
Multiple effects of the special ATâ•'rich binding protein 1 (SATB1) in colon carcinoma

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology

C:/Users/julia/biotechnologische Studenteninitiative (btS) e.V/Leipzig -  ScieGuide 2019/ScieGuide final 08.08/ScieGuide070819.sl
C:/Users/julia/biotechnologische Studenteninitiative (btS) e.V/Leipzig - ScieGuide 2019/ScieGuide final 08.08/ScieGuide070819.sl

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology

Loop | Achim Aigner
Loop | Achim Aigner

SiRNA-transfection of SKOV-3-Luc cells with the Biontex K2® Transfection  System Dipl.-Chem. Alexander Ewe, Prof. Achim Aigner U
SiRNA-transfection of SKOV-3-Luc cells with the Biontex K2® Transfection System Dipl.-Chem. Alexander Ewe, Prof. Achim Aigner U

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology

Tyrosine-Modification of Polypropylenimine (PPI) and Polyethylenimine (PEI)  Strongly Improves Efficacy of siRNA-Mediated Gene Kn
Tyrosine-Modification of Polypropylenimine (PPI) and Polyethylenimine (PEI) Strongly Improves Efficacy of siRNA-Mediated Gene Kn

Nanoparticle-mediated delivery of small RNA molecules in tumor therapy
Nanoparticle-mediated delivery of small RNA molecules in tumor therapy

PDF) The proto-oncogene Pim-1 is a target of miR-33a | Marshall Thomas -  Academia.edu
PDF) The proto-oncogene Pim-1 is a target of miR-33a | Marshall Thomas - Academia.edu

Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes

Achim Aigner | Leipzig University, Germany | Pharmaceutica 2017 |  Conferenceseries
Achim Aigner | Leipzig University, Germany | Pharmaceutica 2017 | Conferenceseries

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology

Let Life Sciences meet you Let Life Sciences meet you
Let Life Sciences meet you Let Life Sciences meet you

Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer  Cells In Vitro and In Vivo
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo

Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes

Untersuchung der biologischen Aktivität von Nanopartikeln in Tumor-  schnittkulturen
Untersuchung der biologischen Aktivität von Nanopartikeln in Tumor- schnittkulturen

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology